News & Events

What We’re Up To

See where we’re heading and what we’ve been up to in news and announcements below.

Filter News

Invetech’s Formulate and Fill Platform Wins Fortive Innovation Award

Invetech’s Formulation and Fill Platform for cell and gene therapy has been awarded a medal for innovation at Fortive’s 2019 Growth & Innovation Conference.

Janet O’Meara Appointed as Vice President, Finance at Invetech

Invetech has announced the appointment of Janet O’Meara as Vice President, Finance.

Odin Technologies Wins Diagnostics Track at INVEST Pitch Perfect Contest

Odin Technologies’ intelligent wearable medical device for diagnosing compartment syndrome won the diagnostics track at the Pitch Perfect startup competition. The track was sponsored by Invetech.

Gerald Kent to Lead Invetech’s Global Diagnostics Division

Invetech has announced the appointment of Gerald Kent as Global Vice President Operations, Diagnostics.

Invetech and Hitachi Chemical Advanced Therapeutics Announcement

Invetech and Hitachi Chemical Advanced Therapeutics Solutions announce an agreement to commercialize an automated platform for cell therapy manufacturing.

Invetech Expands IVD Contract Manufacturing Offering to the United States

Invetech’s Dover Motion division receives ISO 13485 certification for the manufacture of IVD instruments.

Upcoming Events

Connect with our team at one of these upcoming industry events, conferences and tradeshows.

Molecular Med Tri-Con (MMTC)

We’ll be attending the Molecular Med Tri-Con (MMTC) 2020 Conference from March 1-4, 2020 in San Francisco, California.

BPI West

We will be in Santa Clara, CA March 9-12, 2020 for BioProcess International US West, the leading phase-based bioprocessing event for advancing promising biologics towards commercial success. 

Analytica

March 31, 2020 – April 3, 2020 we’ll be in Munich, Germany for the Analytica conference.

Let’s work together

Our scientists, engineers, designers and program managers know what it takes to make your most important project a success.

Contact us